HPMPC, a Broad‐Spectrum Topical Antiviral Agent, Inhibits Herpes Simplex Virus Type 1 Replication and Promotes Healing of Dendritic Keratitis in the New Zealand Rabbit Ocular Model
作者:
Y. Gordon,
E. Romanowski,
T. Araullo-Cruz,
期刊:
Cornea
(OVID Available online 1994)
卷期:
Volume 13,
issue 6
页码: 516-520
ISSN:0277-3740
年代: 1994
出版商: OVID
关键词: HPMPC;Herpes simplex virus type 1
数据来源: OVID
摘要:
Previously, we demonstrated that HPMPC, a new, broad-spectrum antiviral agent, inhibited adenovirus type 5 in the New Zealand (NZ) rabbit ocular model (Cornea 1992; 11:529–33). Historically, no antiviral agent has been demonstrated to be effective against both herpes simplex virus type 1 (HSV-1) and adenovirus eye infections in an experimental animal model. In this study, we compared topical 0.2% HPMPC to 1% trifluridine and vehicle control in the NZ rabbit HSV-1 keratitis model. Using a double-masked, two-eye design, NZ rabbits were inoculated in both eyes with HSV-1 W strain (105pfu/eye), and dendritic keratitis and HSV-1 ocular titers were measured serially. Compared with the control group, both topical 0.2% HPMPC and 1% trifluridine significantly reduced healing time of HSV-1 dendritic keratitis, lowered HSV-1 ocular titers on days 3 through 11, and shortened duration of HSV-1 shedding in the tear film. For all outcome parameters measured, topical 0.2% HPMPC was as effective as 1% trifluridine. A new concept of a broad-spectrum topical antiviral agent was shown to be effective against HSV-1 in an NZ rabbit keratitis model, and further development toward clinical application appears desirable.
点击下载:
PDF
(391KB)
返 回